HCW Biologics (HCWB) Long-Term Investments (2020 - 2025)

HCW Biologics (HCWB) has 6 years of Long-Term Investments data on file, last reported at $1.3 million in Q4 2025.

• Quarterly Long-Term Investments fell 17.09% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (down 17.09% YoY) and the FY2025 annual result came in at $1.3 million, down 17.09% from the prior year.
• Long-Term Investments was little changed at $1.3 million in Q4 2025, from $1.3 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $11.6 million in Q3 2021 to a low of $1.3 million in Q3 2025.
• A 5-year average of $4.1 million and a median of $1.6 million in 2022 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2021 — Long-Term Investments surged 620.13% — and 2022, when it tumbled 86.12%.
• Tracing HCWB's Long-Term Investments over 5 years: stood at $11.5 million in 2021, then tumbled by 86.12% to $1.6 million in 2022, then increased by 0.02% to $1.6 million in 2023, then retreated by 0.02% to $1.6 million in 2024, then slipped by 17.09% to $1.3 million in 2025.
• The last three Long-Term Investments figures came in at $1.3 million (Q4 2025), $1.3 million (Q3 2025), and $3.3 million (Q2 2025), per Business Quant data.